<!DOCTYPE html>
<html>
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Apple macOS version 5.8.0">
<meta http-equiv="Content-Type" content=
"text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
        {font-family:Wingdings;
        panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:"Calibri Light";
        panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:0cm;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
h1
        {mso-style-link:"Heading 1 Char";
        margin-top:12.0pt;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:0cm;
        margin-bottom:.0001pt;
        line-height:107%;
        page-break-after:avoid;
        font-size:16.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;
        font-weight:normal;}
h3
        {mso-style-link:"Heading 3 Char";
        margin-top:2.0pt;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:0cm;
        margin-bottom:.0001pt;
        line-height:107%;
        page-break-after:avoid;
        font-size:12.0pt;
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;
        font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:36.0pt;
        margin-bottom:.0001pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:0cm;
        margin-left:36.0pt;
        margin-bottom:.0001pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
        {margin-top:0cm;
        margin-right:0cm;
        margin-bottom:8.0pt;
        margin-left:36.0pt;
        line-height:107%;
        font-size:11.0pt;
        font-family:"Calibri",sans-serif;}
span.Heading1Char
        {mso-style-name:"Heading 1 Char";
        mso-style-link:"Heading 1";
        font-family:"Calibri Light",sans-serif;
        color:#2F5496;}
span.Heading3Char
        {mso-style-name:"Heading 3 Char";
        mso-style-link:"Heading 3";
        font-family:"Calibri Light",sans-serif;
        color:#1F3763;}
.MsoChpDefault
        {font-family:"Calibri",sans-serif;}
.MsoPapDefault
        {margin-bottom:8.0pt;
        line-height:107%;}
@page WordSection1
        {size:595.3pt 841.9pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
 /* List Definitions */
 ol
        {margin-bottom:0cm;}
ul
        {margin-bottom:0cm;}
-->
</style>
<title></title>
</head>
<body lang="EN-AU">
<div class="WordSection1">
<h1><span lang="EN-US" style=
'font-size:15.0pt;line-height:107%'>2008B04 Briefly outline the
pharmacology of ketamine with reference to its use as an analgesic
agent in the post-operative period.</span></h1>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>List:</span></h3>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Physicochemical</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Pharmacokinetic</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Pharmacodynamic</span></p>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Pharmaceutics:</span></h3>
<p class="MsoListParagraphCxSpFirst" style=
'margin-bottom:0cm;margin-bottom:.0001pt; text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Stable in solution</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-bottom:0cm;margin-bottom: .0001pt;text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">No toxic additives (benzethonium chloride:
theoretical risk of neurotoxicity)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-bottom:0cm;margin-bottom: .0001pt;text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Low risk of bacterial growth (suitable for slow
infusion in single syringe)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-bottom:0cm;margin-bottom: .0001pt;text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">No precipitation</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-bottom:0cm;margin-bottom: .0001pt;text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Low risk anaphylaxis</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-bottom:0cm;margin-bottom:.0001pt; text-align:justify;text-indent:-18.0pt'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>
<span lang="EN-US">Not painful on injection (suitable for
peripheral IV)</span></p>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Pharmacokinetics:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Administration</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Common routes for analgesia (not just
post-op&acirc;&euro;&brvbar;)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">IV bolus 0.1-0.3mg/kg (e.g. rescue in
PACU, fracture manipulation in A&amp;E)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">IV infusion 0.1-0.2mg/kg/h (e.g. days 1-2
post-op)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:66.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: Wingdings'>&Acirc;&sect;
</span><span lang="EN-US">Useful if NBM</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:66.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: Wingdings'>&Acirc;&sect;
</span><span lang="EN-US">Titratable</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:66.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: Wingdings'>&Acirc;&sect;
</span><span lang="EN-US">Avoids peaks/troughs hence toxicity e.g.
delirium</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Sublingual PRN: 0.3mg/kg q5min (e.g.
dressing changes)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">PO: 0.5mg/kg tds (e.g. on
ward)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">IN 0.5-1mg/kg q15mins (e.g. procedural
sedation in children)</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Time course</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">IV: onset 30 seconds, peak 90 seconds, duration
varies</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">SL: onset 10-30 mins, duration 2-4
hours</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">PO: onset 30 mins, duration 2-4 hours</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Absorption (bioav)</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">PO: 16% (first pass ++)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">SL ~30%</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">IN 50%</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">PR 25%</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Distribution</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Rapid effect site equilibration
(t<sub>1/2ke0</sub> 0.5 mins)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Highly lipid soluble (5-10x thiopentone)
&acirc;&euro;&OpenCurlyDoubleQuote; crosses placenta</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Low plasma protein binding
(25%)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Hence suitable for small rescue bolus in
PACU</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Large V<sub>DSS</sub> 3L/kg and rapid
distribution</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Hence intra-operative loading dose
recommended</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Metabolism</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Hepatic phase 1, CYP3A4 N-demethylation &gt;
other</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Active metabolite norketamine (30% as
active)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">May prolong duration</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Inactivated by hydroxylation then
conjugation</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">t<sub>1/2</sub></span><sub><span lang=
"EN-US">&Icirc;&sup2;</span></sub> <span lang="EN-US">4
hours</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Rapid Clearance 17mL/kg/min, short t1/2b 2
hours</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Suitable for infusion</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Risk of hepatotoxicity if infused</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Check LFTs second daily</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Excretion</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraph" style=
'margin-top:0cm;margin-right:0cm;margin-bottom: 0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify;text-indent: -9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Active and inactive metabolites renally
excreted</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Analgesia:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Mechanisms</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Primary: non-competitive NMDA antagonist at PCP
site</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Post-synaptic inhibition at dorsal
horn</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Short term:
&acirc;&dagger;&OpenCurlyDoubleQuote;excitability,
&acirc;&dagger;&OpenCurlyDoubleQuote;wind-up</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-indent:-9.0pt; line-height:normal'>
<span lang="EN-US" style='font-family:"Courier New"'>o
</span><span lang="EN-US">Long term:
&acirc;&dagger;&OpenCurlyDoubleQuote;synaptic reinforcement,
&acirc;&dagger;&OpenCurlyDoubleQuote;long-term
potentiation</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Secondary:
&acirc;&dagger;&OpenCurlyDoubleQuote;Monoamine reuptake,
&acirc;&dagger;&OpenCurlyDoubleQuote;VDNaC,
&acirc;&dagger;&OpenCurlyQuote;mu opioid</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">S-ketamine 2-4x more potent than
R-ketamine</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">Effects</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">&acirc;&dagger;&OpenCurlyDoubleQuote;Acute and
chronic pain</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">&acirc;&dagger;&OpenCurlyDoubleQuote;Somatic and
neuropathic pain</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang=
"EN-US">&acirc;&dagger;&OpenCurlyDoubleQuote;Hyperalgaesia and
allodynia</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang=
"EN-US">&acirc;&dagger;&OpenCurlyDoubleQuote;</span><i><span lang=
"EN-US">Risk</span></i> <span lang="EN-US">of chronic pain, phantom
pain</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">&acirc;&dagger;&OpenCurlyDoubleQuote;Opioid
requirement</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">&acirc;&euro;&oelig;Re-set&acirc;&euro; opioid
sensitivity in opioid-induced hyperalgaesia</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<h3><span lang="EN-US" style=
'font-size:13.0pt;line-height:107%'>Side effects:</span></h3>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding=
"0" style='border-collapse:collapse;border:none'>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal'>
<span lang="EN-US">CNS</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Delirium: nightmares, hallucinations</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">Dose-dependent</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">May be attenuated by midazolam (e.g. 1mg
with 200mg ketamine)</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">High risk of psychiatric
illness</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:39.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style='font-family: "Courier New"'>o
</span><span lang="EN-US">R-ketamine &gt; S-ketamine</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">&acirc;&dagger;&OpenCurlyQuote;CMRO<sub>2</sub>,
&acirc;&dagger;&OpenCurlyQuote;CBF, +/- ICP (contraindicated if CNS
bleed, tumour with &acirc;&dagger;&OpenCurlyQuote;ICP)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Dependence, addiction</span></p>
</td>
</tr>
<tr>
<td width="126" valign="top" style=
'width:94.25pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal'>
<span lang="EN-US">Uncommon at analgesic dose</span></p>
</td>
<td width="526" valign="top" style=
'width:394.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt'>
<p class="MsoListParagraphCxSpFirst" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">CNS: dissociative anaesthesia,
nausea/vomiting</span></p>
<p class="MsoListParagraphCxSpMiddle" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-align:justify; text-indent:-9.0pt;line-height:normal'>
<span lang="EN-US" style=
'font-family: Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">CVS: SNS stimulation, direct negative inotropy,
vasodilation (R &gt; S-ketamine)</span></p>
<p class="MsoListParagraphCxSpLast" style=
'margin-top:0cm;margin-right:0cm; margin-bottom:0cm;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt; line-height:normal'>
<span lang="EN-US" style=
'font-family:Symbol'>&Acirc;&CenterDot;<span style=
'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;</span></span>
<span lang="EN-US">Resp: mild
&acirc;&dagger;&OpenCurlyDoubleQuote;minute ventilation,
&acirc;&dagger;&OpenCurlyQuote;airway secretions,
bronchodilation<br>
(bronchodilation R &gt; S-ketamine)</span></p>
</td>
</tr>
</table>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
<p class="MsoNormal" style=
'margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify'>
<span lang="EN-US">&nbsp;</span></p>
</div>
<p class="MsoNormal">Feedback welcome at <a href=
"mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>
</body>
</html>
